[Molecular markers in hematology and oncology]

Praxis (Bern 1994). 2010 Sep 22;99(19):1143-52. doi: 10.1024/1661-8157/a000234.
[Article in German]

Abstract

Molecular diagnostics examines the basic molecules of the genome for relevant aberrations, according to diagnosis, prognosis and therapy. It depends mainly on PCR-based methods (qualitative and quantitative analysis, RT-PCR, nested PCR, melting curve analysis, sequencing etc.). The general practitioner or consultant in internal medicine encounters molecular diagnostics by his evaluations of the reasons for thromboembolism (mutation of factor V Leiden or prothrombin), myeloproliferative neoplasms (JAK2V617F-mutation, BCR-ABL1) or hemochromatosis. The specialist furthermore appreciates its value in diagnosis and treatment monitoring of acute and chronic leukemia, lymphoma, familial erythrocytosis and a variety of solid tumors (especially breast cancer and colorectal carcinoma), as well as in managing refractory transfusion answers, suspected disturbances in drug metabolism and in the planning of an allogeneic stem cell transplantation.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Family Practice
  • Genetic Markers / genetics*
  • Hemochromatosis / diagnosis
  • Hemochromatosis / genetics*
  • Hemochromatosis / therapy
  • Humans
  • Internal Medicine
  • Leukemia / diagnosis
  • Leukemia / genetics*
  • Leukemia / therapy
  • Lymphoma / diagnosis
  • Lymphoma / genetics*
  • Lymphoma / therapy
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / therapy
  • Neoplasms / diagnosis
  • Neoplasms / enzymology*
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • Patient Care Team
  • Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Analysis, DNA
  • Thromboembolism / diagnosis
  • Thromboembolism / genetics*
  • Thromboembolism / therapy

Substances

  • Genetic Markers